Skip to main content

Table 3 Prevalence (%) of active headache disorder by type, gender and timeframe

From: The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

Timeframe Headache Migraine TTH H15+
N Mean 95% CI N Mean 95% CI N Mean 95% CI/ N Mean 95% CI
Lifetime
 Both genders 42 66.6 58.8–73.9 49 17.5 14.6–21.0 18 40.6 30.0–51.4 9 4.5 1.8–7.7
 Males 28 65.0 53.8–74.4 39 11.6 9.1–14.8 9 35.7 19.6–52.6 6 1.9 0.9–3.1
 Females 28 73.3 63.3–83.2 41 21.0 17.3–25.4 9 43.8 26.5–61.8 6 4.5 2.2–7.5
1-year
 Both genders 110 53.5 49.1–57.7 150 15.3 13.7–16.9 77 26.4 22.9–30.3 50 4.8 4.0–5.7
 Males 73 46.4 41.1–51.7 112 9.1 7.9–10.3 47 24.2 19.2–29.6 39 2.9 2.2–3.8
 Females 72 60.5 55.1–65.8 113 18.1 16.3–29.9 48 28.5 22.7–34.3 39 6.2 4.9–7.6
6-month, both genders 15 60.9 50.6–71.3 12 11.1 6.7–16.9 9 32.2 15.1–50.8 2 6.0 4.8–7.2
3-month, both genders 12 52.2 36.5–66.6 10 13.4 9.1–17.9 5 20.2 2.1–38.6 3 2.7 2.2–3.3
“Current”, both genders 3 37.2 10 12.9 7.7–18.3 0 0
Unknown, both genders 43 45.9 38.5–53.1 62 11.9 10.0–14.0 19 22.9 17.2–29.2 4 3.4 1.5–5.4
1-day
 Both genders 12 15.8 10.0–22.0 5 7.0 4 8.7 3 2.5
 Males 8 8.0 4.0–12.8 2 2.4 1 5.1 1 1.8
 Females 8 14.9 8.9–21.7 2 5.5 1 10.1 1 4.4
All timeframes, both genders 237 52.7 49.7–55.8 298 14.5 13.4–15.5 132 27.4 24.2–30.9 71 4.5 3.9–5.2
  1. N number of studies, TTH tension-type headache, H15+ headache on ≥15 days/month, CI confidence interval (not given when N ≤ 5)